28160280|t|Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research
28160280|a|Research imaging of brain structure and function has helped to elucidate the pathophysiology of medication overuse headache (MOH). This is a narrative review of imaging research studies that have investigated brain structural and functional alterations associated with MOH. Studies included in this review have investigated abnormal structure and function of pain processing regions in people with MOH, functional patterns that might predispose individuals to development of MOH, similarity of brain functional patterns in patients with MOH to those found in people with addiction, brain structure that could predict headache improvement following discontinuation of the overused medication, and changes in brain structure and function after discontinuation of medication overuse. MOH is associated with atypical structure and function of brain regions responsible for pain processing as well as brain regions that are commonly implicated in addiction. Several studies have shown "normalization" of structure and function in pain processing regions following discontinuation of the overused medication and resolution of MOH. However, some of the abnormalities in regions also implicated in addiction tend to persist following discontinuation of the overused medication, suggesting that they are a brain trait that predisposes certain individuals to medication overuse and MOH.
28160280	0	27	Medication Overuse Headache	T046	C2349423
28160280	29	47	Pathophysiological	T169	C0031847
28160280	62	72	Structural	T082	C0678594
28160280	77	87	Functional	T169	C0205245
28160280	88	93	Brain	T023	C0006104
28160280	94	97	MRI	T060	C0024485
28160280	98	106	Research	T062	C0035168
28160280	107	115	Research	T062	C0035168
28160280	116	123	imaging	T060	C0024485
28160280	127	142	brain structure	T023	C0006104
28160280	147	155	function	T042	C0678908
28160280	184	199	pathophysiology	T046	C0277785
28160280	203	230	medication overuse headache	T046	C2349423
28160280	232	235	MOH	T046	C2349423
28160280	268	275	imaging	T060	C0024485
28160280	276	284	research	T062	C0035168
28160280	285	292	studies	T062	C2603343
28160280	316	321	brain	T023	C0006104
28160280	322	332	structural	UnknownType	C0549658
28160280	337	359	functional alterations	T046	C0277785
28160280	376	379	MOH	T046	C2349423
28160280	381	388	Studies	T062	C2603343
28160280	431	439	abnormal	T033	C0205161
28160280	440	449	structure	T082	C0678594
28160280	454	462	function	T169	C0542341
28160280	466	470	pain	T184	C0030193
28160280	493	499	people	T098	C0027361
28160280	505	508	MOH	T046	C2349423
28160280	510	529	functional patterns	T169	C0205245
28160280	552	563	individuals	T098	C0237401
28160280	582	585	MOH	T046	C2349423
28160280	601	606	brain	T023	C0006104
28160280	607	626	functional patterns	T169	C0205245
28160280	630	638	patients	T101	C0030705
28160280	644	647	MOH	T046	C2349423
28160280	666	672	people	T098	C0027361
28160280	678	687	addiction	T048	C0085281
28160280	689	704	brain structure	T023	C0006104
28160280	724	732	headache	T184	C0018681
28160280	755	770	discontinuation	T058	C0457454
28160280	787	797	medication	T058	C2081612
28160280	814	829	brain structure	T023	C0006104
28160280	834	842	function	T169	C0542341
28160280	849	864	discontinuation	T058	C0457454
28160280	868	878	medication	T058	C2081612
28160280	879	886	overuse	T055	C3266697
28160280	888	891	MOH	T046	C2349423
28160280	920	929	structure	T082	C0678594
28160280	934	942	function	T169	C0542341
28160280	946	959	brain regions	T023	C0006104
28160280	976	980	pain	T184	C0030193
28160280	1003	1016	brain regions	T023	C0006104
28160280	1049	1058	addiction	T048	C0085281
28160280	1068	1075	studies	T062	C2603343
28160280	1106	1115	structure	T082	C0678594
28160280	1120	1128	function	T169	C0542341
28160280	1132	1136	pain	T184	C0030193
28160280	1166	1181	discontinuation	T058	C0457454
28160280	1198	1208	medication	T058	C2081612
28160280	1227	1230	MOH	T046	C2349423
28160280	1253	1266	abnormalities	T033	C1704258
28160280	1297	1306	addiction	T048	C0085281
28160280	1333	1348	discontinuation	T058	C0457454
28160280	1365	1375	medication	T058	C2081612
28160280	1404	1409	brain	T023	C0006104
28160280	1441	1452	individuals	T098	C0237401
28160280	1456	1466	medication	T058	C2081612
28160280	1467	1474	overuse	T055	C3266697
28160280	1479	1482	MOH	T046	C2349423